Other Affiliated Sites
Simplified Chinese
Traditional Chinese
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
Global Industrial Chain
Global Heparin Injections Business
Product Profile
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Contact Us
Create Value for Investors Through
Safe and Stable Operations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Disclosures
A-Share Information
H-Share Information
Financial Reports
Announcements
2016.09.19
2016年第二次临时股东大会的法律意见书
2016.09.19
2016年第二次临时股东大会决议公告
2016.08.29
关于申请内保外贷暨为全资子公司提供反担保的公告
2016.08.29
关于召开2016年第二次临时股东大会的通知公告
2016.08.29
第三届监事会第十七次会议决议公告
2016.08.29
第三届董事会第二十五次会议决议公告
2016.08.29
关于公司使用自有资金对TPG BIOTECHNOLOGY PARTNERS V, L.P.投资的进展公告
2016.08.29
2016年半年度财务报告
2016.08.29
董事会关于募集资金2016年半年度存放与使用情况的专项报告
2016.08.09
关于控股股东股权解除质押的公告
第一页
上一页
88
89
90
91
92
下一页
最后一页
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Contact Us
Official WeChat Account
Legal Statement
·
Environmental Disclosure
Copyright © 2024 Hepalink Group. All Rights Reserved.
站点地图
